Characteristic | Details |
---|---|
Active Ingredients | Sildenafil Citrate 100 mg, Duloxetine 30 mg |
Form | Tablet |
Strength | 100 mg / 30 mg |
Route of Administration | Oral |
Manufacturer | Sunrise Remedies |
Visit Official Site |
Pharmacokinetics
Malegra DXT Plus combines sildenafil citrate and duloxetine. Sildenafil citrate, at a dosage of 100 mg, enhances blood flow in the penile region by inhibiting phosphodiesterase type 5 (PDE5). Duloxetine, at 30 mg, modulates neurotransmitters in the central nervous system, influencing mood and anxiety.
The absorption of sildenafil occurs rapidly. Maximum plasma concentrations are reached within 30 to 120 minutes post-administration. Food intake delays this process. Duloxetine reaches peak levels approximately 6 hours after ingestion. The bioavailability of duloxetine is affected by its extensive first-pass metabolism.
The half-life of sildenafil citrate ranges from 3 to 5 hours, and it is primarily metabolized by the liver. Duloxetine has a half-life of about 12 hours, necessitating cautious administration in hepatic dysfunction. Both components exhibit renal and fecal excretion pathways.
Areas of Use
Malegra DXT Plus serves in the domain of erectile dysfunction and premature ejaculation. Sildenafil citrate enhances erectile function, while duloxetine extends ejaculatory latency, assisting men with premature ejaculation issues.
The dual mechanism of action addresses two prevalent concerns in male sexual health. This combination offers a comprehensive solution, enhancing both erectile rigidity and ejaculatory control. Healthcare professionals consider this therapeutic approach for patients with concurrent sexual dysfunctions.
Malegra DXT Plus targets the underlying physiological and psychological aspects of these conditions. This dual-action tablet represents a holistic treatment avenue, balancing efficacy and patient satisfaction.
FDA-Approved Indications
The U.S. FDA has sanctioned sildenafil citrate for erectile dysfunction. However, the combination with duloxetine in Malegra DXT Plus does not hold specific FDA approval. Duloxetine is recognized for treating major depressive disorder and generalized anxiety disorder.
The use of this combination falls within off-label prescribing practices. Physicians prescribe it based on clinical judgment and patient-specific needs. The combination’s pharmacodynamic properties warrant cautious consideration.
Regulatory bodies emphasize understanding potential interactions and contraindications. Prescribers should assess patient history and co-morbidities before initiating treatment with this formulation.
Malegra DXT Plus Storage
Store Malegra DXT Plus at room temperature, between 20°C and 25°C. Protect from moisture and light to preserve stability. Avoid storing in bathrooms or damp environments.
Keep this medication out of reach of children and pets. Proper storage is crucial for maintaining the efficacy of the active components. Ensure the packaging is intact to prevent contamination.
Follow the manufacturer’s guidelines regarding shelf life. Discard any unused tablets past the expiration date to ensure patient safety.
Toxicity
Malegra DXT Plus may pose risks if not used appropriately. Overdose of sildenafil can lead to severe hypotension, priapism, and cardiac complications. Duloxetine overdose may result in serotonin syndrome, seizures, and hepatic injury.
Recognize symptoms of toxicity early. Patients should seek immediate medical attention if experiencing severe adverse reactions. The risk of drug interactions necessitates cautious co-administration with other medications.
Healthcare providers should counsel patients on recognizing potential side effects. An open patient-provider communication channel is essential for monitoring safety and efficacy during treatment.
Where to Buy Malegra DXT Plus Online
Malegra DXT Plus is available through various online platforms. Patients should seek reliable pharmacies with verified credentials. It is essential to prioritize safety and authenticity when purchasing online.
Consultation with a healthcare provider before purchasing ensures informed decision-making. An understanding of the patient’s health status and current medications facilitates safe acquisition.
It is advisable to refer to scientific resources for detailed product information. This source can be invaluable for further reading and patient education.
Data source:
- https://kgisimmigration.com/2024/07/03/chlamydia-psittaci-infection-an-internal-medicine-perspective/
- https://tm-profi-gmbh.ch/goldenhar-syndrome-unraveling-the-complexities-of-treatment/
- https://www.synergisolutions.net/vector-borne-diseases-insights-and-implications/
- https://umerfarooq.live/krintafel-an-ally-against-malaria-recurrence/
- https://qa-marketing.owlpractice-dev.com/bartonella-quintana-infection-and-respiratory-health/
- https://ensino.faspec.edu.br/2024/08/01/utforsker-azasites-rolle-i-a-administrere-familiens-helsehistorie/
- https://jbkenglishclasses.com/infertility-a-medical-challenge/
- https://www.choiceeducationalacademy.com/utforska-amisulprids-potential-vid-behandling-av-invasiv-candidiasis/
- https://microquim.net/infecciones-causadas-por-vepesid-en-el-tratamiento-del-cancer/
- https://cotswold-educare-preprimary.co.za/2023/12/22/fluticasone-propionate-inhalers-a-shield-against-avian-influenza/
- https://mudanzasbarajas.com/la-vacunacion-contra-el-sarampion-un-componente-crucial-de-la-salud-publica/
- https://homentique.ma/exploration-du-role-du-clorazepate-dipotassique-dans-la-prise-en-charge-du-lymphome-de-burkitt/
- https://credijamar.com.co/explorando-betapace-impacto-en-el-tratamiento-y-manejo-de-la-paralisis-cerebral/